A Six-Week Safety Study of an Investigational Ophthalmic Solution
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the ocular safety of an investigational ophthalmic
solution in subjects 2 years of age and older with asymptomatic eyes when administered once
daily in both eyes for up to 6 weeks.